Metallothionein prolongs survival and antagonizes senescence‐associated cardiomyocyte diastolic dysfunction: role of oxidative stress

Senescence is accompanied by oxidative stress and cardiac dysfunction, although the link between the two remains unclear. This study examined the role of antioxidant metallothionein on cardiomyocyte function, superoxide generation, the oxidative stress biomarker aconitase activity, cytochrome c release, and expression of oxidative stress‐related proteins, such as the GTPase RhoA and NADPH oxidase protein p47phox in young (5–6 mo) and aged (26–28 mo) FVB wild‐type (WT) and cardiac‐specific metallothionein transgenic mice. Metallothionein mice showed a longer life span (by ∼4 mo) than FVB mice evaluated by the Kaplan‐Meier survival curve. Compared with young cardiomyocytes, aged myocytes displayed prolonged TR90, reduced tolerance to high stimulus frequency, and slowed intracellular Ca2+ decay, all of which were nullified by metallothionein. Aging increased superoxide generation, active RhoA abundance, cytochrome c release, and p47phox expression and suppressed aconitase activity without affecting protein nitrotyrosine formation in the hearts. These aging‐induced changes in oxidative stress and related protein biomarkers were attenuated by metallothionein. Aged metallothionein mouse myocytes were more resistant to the superoxide donor pyrogallol‐induced superoxide generation and apoptosis. In addition, aging‐associated prolongation in TR90 was blunted by the Rho kinase inhibitor Y‐27632. Collectively, our data demonstrated that metallothionein may alleviate aging‐induced cardiac contractile defects and oxidative stress, which may contribute to prolonged life span in metallothionein transgenic mice.—Yang, X., Doser, T. A., Fang, C. X., Nunn, J. M., Janardhanan, R., Zhu, M., Sreejayan, N., Quinn, M. T., Ren, J. Metallothionein prolongs survival and antagonizes senescence‐associated cardiomyocyte diastolic dysfunction: role of oxidative stress FASEB J. 20, E260–E270 (2006)

[1]  K. Homma,et al.  Rho‐kinase as a molecular target for insulin resistance and hypertension , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[2]  C. Fang,et al.  Metallothionein alleviates cardiac contractile dysfunction induced by insulin resistance: role of Akt phosphorylation, PTB1B, PPARγ and c-Jun , 2005, Diabetologia.

[3]  Animesh Nandi,et al.  Suppression of Aging in Mice by the Hormone Klotho , 2005, Science.

[4]  Jun Ren,et al.  Dietary iron deficiency induces ventricular dilation, mitochondrial ultrastructural aberrations and cytochrome c release: involvement of nitric oxide synthase and protein tyrosine nitration. , 2005, Clinical science.

[5]  P. Arthur,et al.  Role of NAD(P)H oxidase in the regulation of cardiac L-type Ca2+ channel function during acute hypoxia. , 2005, Cardiovascular research.

[6]  J. T. Saari,et al.  Cardiac metallothionein synthesis in streptozotocin-induced diabetic mice, and its protection against diabetes-induced cardiac injury. , 2005, The American journal of pathology.

[7]  M. Emond,et al.  Extension of Murine Life Span by Overexpression of Catalase Targeted to Mitochondria , 2005, Science.

[8]  J. Liao,et al.  Rho-Kinase Mediates Hyperglycemia-Induced Plasminogen Activator Inhibitor-1 Expression in Vascular Endothelial Cells , 2005, Circulation.

[9]  L. Cai,et al.  Inhibition of superoxide generation and associated nitrosative damage is involved in metallothionein prevention of diabetic cardiomyopathy. , 2005, Diabetes.

[10]  L. Wold,et al.  Endothelin‐1 enhances oxidative stress, cell proliferation and reduces apoptosis in human umbilical vein endothelial cells: role of ETB receptor, NADPH oxidase and caveolin‐1 , 2005, British journal of pharmacology.

[11]  R. S. Sohal,et al.  Aconitase and ATP synthase are targets of malondialdehyde modification and undergo an age-related decrease in activity in mouse heart mitochondria. , 2005, Biochemical and biophysical research communications.

[12]  C. Wilbert,et al.  Aging induces cardiac diastolic dysfunction, oxidative stress, accumulation of advanced glycation endproducts and protein modification , 2005, Aging cell.

[13]  Xiaoping Yang,et al.  Views from within and beyond , 2005, Endocrine.

[14]  C. Fang,et al.  Small guanine nucleotide-binding protein Rho and myocardial function , 2005, Acta Pharmacologica Sinica.

[15]  S. Ledoux,et al.  Mitochondrial DNA and aging. , 2004, Clinical science.

[16]  Z. Ying,et al.  Activation of Rho/Rho kinase signaling pathway by reactive oxygen species in rat aorta. , 2004, American journal of physiology. Heart and circulatory physiology.

[17]  C. Des Rosiers,et al.  Decreased cardiac mitochondrial NADP+-isocitrate dehydrogenase activity and expression: a marker of oxidative stress in hypertrophy development. , 2004, American journal of physiology. Heart and circulatory physiology.

[18]  S. Davidge,et al.  Cardioprotection by chronic estrogen or superoxide dismutase mimetic treatment in the aged female rat. , 2004, American journal of physiology. Heart and circulatory physiology.

[19]  D. Seals,et al.  Ascorbic acid increases cardiovagal baroreflex sensitivity in healthy older men. , 2004, American journal of physiology. Heart and circulatory physiology.

[20]  I. Fridovich.  Mitochondria: are they the seat of senescence? , 2004, Aging cell.

[21]  H. Kawamura,et al.  High Glucose-Induced Upregulation of Osteopontin Is Mediated via Rho/Rho Kinase Pathway in Cultured Rat Aortic Smooth Muscle Cells , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[22]  R. Ferrari,et al.  Oxidative stress in cardiovascular disease: myth or fact? , 2003, Archives of biochemistry and biophysics.

[23]  C. Des Rosiers,et al.  Cardiac Mitochondrial NADP+-isocitrate Dehydrogenase Is Inactivated through 4-Hydroxynonenal Adduct Formation , 2003, Journal of Biological Chemistry.

[24]  D. Harrison,et al.  The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. , 2003, Trends in pharmacological sciences.

[25]  Alex F. Chen,et al.  Perspectives on the cardioprotective effects of statins. , 2003, Current medicinal chemistry.

[26]  Jun Ren,et al.  Metallothionein prevents diabetes-induced deficits in cardiomyocytes by inhibiting reactive oxygen species production. , 2003, Diabetes.

[27]  Jun Ren,et al.  Impaired cardiac function and IGF-I response in myocytes from calmodulin-diabetic mice: role of Akt and RhoA. , 2003, American journal of physiology. Endocrinology and metabolism.

[28]  Daniel Levy,et al.  Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part II: the aging heart in health: links to heart disease. , 2003, Circulation.

[29]  John H. Zhang,et al.  Age-related RhoA expression in blood vessels of rats , 2001, Mechanisms of Ageing and Development.

[30]  J. L. François,et al.  Fibrillar β-amyloid evokes oxidative damage in a transgenic mouse model of Alzheimer’s disease , 2001, Neuroscience.

[31]  N. Dhalla,et al.  Sarcoplasmic reticulum and cardiac oxidative stress: an emerging target for heart disease , 2001, Expert opinion on therapeutic targets.

[32]  T. Ozben,et al.  Alterations of antioxidant enzymes and oxidative stress markers in aging , 2001, Experimental Gerontology.

[33]  N. Dhalla,et al.  Role of oxidative stress in cardiovascular diseases , 2000, Journal of hypertension.

[34]  R. S. Sohal,et al.  Oxidative damage during aging targets mitochondrial aconitase. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Y. J. Kang,et al.  Overexpression of metallothionein in the heart of transgenic mice suppresses doxorubicin cardiotoxicity. , 1997, The Journal of clinical investigation.

[36]  R. Weindruch,et al.  Oxidative Stress, Caloric Restriction, and Aging , 1996, Science.

[37]  V. Bindokas,et al.  Superoxide production in rat hippocampal neurons: selective imaging with hydroethidine , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[38]  A. Jesaitis,et al.  A Domain of p47phox That Interacts with Human Neutrophil Flavocytochrome b558(*) , 1995, The Journal of Biological Chemistry.

[39]  J. Herrera Acosta.  [Insulin resistance and hypertension]. , 1994, Gaceta medica de Mexico.

[40]  P. R. Gardner,et al.  Inactivation-reactivation of aconitase in Escherichia coli. A sensitive measure of superoxide radical. , 1992, The Journal of biological chemistry.

[41]  E. Stadtman,et al.  Protein modification in aging. , 1988, EXS.

[42]  D. Harman.  The aging process. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[43]  D. Harman.  Aging: a theory based on free radical and radiation chemistry. , 1956, Journal of gerontology.

[44]  Jun Ren,et al.  The oxygen radical generator pyrogallol impairs cardiomyocyte contractile function via a superoxide and p38 MAP kinase-dependent pathway , 2007, Cardiovascular Toxicology.

[45]  Y. Ng,et al.  Age-related alterations in expression of apoptosis regulatory proteins and heat shock proteins in rat skeletal muscle. , 2006, Biochimica et biophysica acta.

[46]  Jun-Ren,et al.  Small guanine nucleotide-binding protein Rho and myocardial function , 2005 .

[47]  Y. Matsuoka,et al.  Fibrillar beta-amyloid evokes oxidative damage in a transgenic mouse model of Alzheimer's disease. , 2001, Neuroscience.

[48]  G. Wang,et al.  Metallothionein-overexpressing neonatal mouse cardiomyocytes are resistant to H2O2toxicity. , 1999, American journal of physiology. Heart and circulatory physiology.

[49]  G. Wang,et al.  Metallothionein-overexpressing neonatal mouse cardiomyocytes are resistant to H 2 O 2 toxicity , 1998 .